Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice
Open Access
- 20 December 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 120 (26), 5217-5223
- https://doi.org/10.1182/blood-2012-06-439935
Abstract
Coronary heart disease is a major cause of death in the western world. Although essential for successful recovery, reperfusion of ischemic myocardium is inevitably associated with reperfusion injury. To investigate a potential protective role of ADAMTS13, a protease cleaving von Willebrand factor multimers, during myocardial ischemia/reperfusion, we used a mouse model of acute myocardial infarction. We found that Adamts13−/− mice developed larger myocardial infarctions than wild-type control mice, whereas treatment of wild-type mice with recombinant human ADAMTS13 (rhADAMTS13) led to smaller infarctions. The protective effect of ADAMTS13 was further confirmed by a significant reduction of cardiac troponin-I release and less myocardial apoptosis in mice that received rhADAMTS13 compared with controls. Platelets adherent to the blood vessel wall were observed in few areas in the heart samples from mice treated with vehicle and were not detected in samples from mice treated with rhADAMTS13. However, we observed a 9-fold reduction in number of neutrophils infiltrating ischemic myocardium in mice that were treated with rhADAMTS13, suggesting a potent anti-inflammatory effect of ADAMTS13 during heart injury. Our data show that ADAMTS13 reduces myocardial ischemia/reperfusion injury in mice and indicate that rhADAMTS13 could be of therapeutic value to limit myocardial ischemia/reperfusion injury.Keywords
This publication has 41 references indexed in Scilit:
- ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in miceBlood, 2012
- Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factorBlood, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for TherapyThe American Journal of Cardiology, 2010
- Myocardial injury in HIV-associated thrombotic thrombocytopenic purpura (TTP)Transfusion Medicine, 2010
- von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental strokeBlood, 2009
- The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formationBlood, 2009
- ADAMTS13: a new link between thrombosis and inflammationThe Journal of Experimental Medicine, 2008
- Usefulness of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Mortality in ST Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2008
- Evidence that high von Willebrand factor and low ADAMTS‐13 levels independently increase the risk of a non‐fatal heart attackJournal of Thrombosis and Haemostasis, 2008